Published in Virology on February 01, 1974
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol (1988) 12.52
Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells. J Virol (1976) 8.73
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A (1982) 7.34
Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J Cell Biol (1981) 7.07
Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity. J Virol (1979) 6.72
Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol (1981) 6.46
Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins. Proc Natl Acad Sci U S A (1977) 5.87
Microbial surfaces in relation to pathogenicity. Bacteriol Rev (1977) 5.79
pH-dependent fusion between the Semliki Forest virus membrane and liposomes. Proc Natl Acad Sci U S A (1980) 5.21
Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol (1987) 3.65
Fusion of Semliki forest virus with the plasma membrane can be induced by low pH. J Cell Biol (1980) 3.47
Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proc Natl Acad Sci U S A (1978) 3.42
Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. Proc Natl Acad Sci U S A (1984) 3.42
Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J Virol (1992) 3.20
Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc Natl Acad Sci U S A (1996) 3.07
Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A (1984) 2.82
Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus. J Virol (1988) 2.66
Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J Virol (1996) 2.63
Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc Natl Acad Sci U S A (1985) 2.56
Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J Virol (1999) 2.51
Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J Virol (1992) 2.47
Viral pathogenesis and molecular biology. Bacteriol Rev (1977) 2.41
Protein-protein interactions within paramyxoviruses identified by native disulfide bonding or reversible chemical cross-linking. J Virol (1980) 2.40
Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J Virol (1985) 2.38
Trypsin enhancement of rotavirus infectivity: mechanism of enhancement. J Virol (1981) 2.29
Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J Virol (2005) 2.25
Intracellular synthesis of measles virus-specified polypeptides. J Virol (1978) 2.21
Polypeptide synthesis in simian virus 5-infected cells. J Virol (1977) 2.20
Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene. J Virol (1990) 2.17
Cell surface expression of fusogenic vesicular stomatitis virus G protein from cloned cDNA. EMBO J (1984) 2.10
Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J Virol (2004) 2.09
Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun (1975) 2.01
Identification and properties of chlamydial polypeptides that bind eucaryotic cell surface components. J Bacteriol (1986) 1.93
Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J Virol (1992) 1.91
Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion. J Virol (1991) 1.91
Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J Virol (1995) 1.89
Antiviral instruction of bone marrow leukocytes during respiratory viral infections. Cell Host Microbe (2010) 1.89
Hemagglutinin-neuraminidase protein of the paramyxovirus simian virus 5: nucleotide sequence of the mRNA predicts an N-terminal membrane anchor. J Virol (1985) 1.87
Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J Virol (2006) 1.81
Formation of protein micelles from amphiphilic membrane proteins. Proc Natl Acad Sci U S A (1978) 1.80
Functional interaction between paramyxovirus fusion and attachment proteins. J Biol Chem (2008) 1.78
Amino acid substitutions in the F-specific domain in the stalk of the newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein. J Virol (2004) 1.78
Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion. J Virol (1992) 1.76
Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J Virol (2005) 1.72
Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces. J Virol (1997) 1.71
Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit. Nucleic Acids Res (1985) 1.69
Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus. J Virol (1988) 1.67
An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J (1990) 1.66
Intracellular processing of the Newcastle disease virus fusion glycoprotein. J Virol (1985) 1.65
Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J Virol (1994) 1.63
Membrane differentiations at sites specialized for cell fusion. J Cell Biol (1977) 1.62
Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J Virol (2006) 1.61
The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J Virol (1988) 1.60
Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J Virol (1995) 1.59
Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity. J Virol (1993) 1.56
Site-directed mutagenesis of a conserved hexapeptide in the paramyxovirus hemagglutinin-neuraminidase glycoprotein: effects on antigenic structure and function. J Virol (1994) 1.54
Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo. EMBO J (1992) 1.54
In vitro replication of Sendai virus wild-type and defective interfering particle genome RNAs. J Virol (1985) 1.53
Identification and predicted sequence of a previously unrecognized small hydrophobic protein, SH, of the paramyxovirus simian virus 5. J Virol (1985) 1.53
Glycoproteins of measles virus under reducing and nonreducing conditions. J Virol (1978) 1.51
Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage. J Virol (1992) 1.50
Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. J Virol (1988) 1.49
Structural characterization of virion proteins and genomic RNA of human parainfluenza virus 3. J Virol (1984) 1.46
Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J Cell Biol (1996) 1.44
Sendai virus utilizes specific sialyloligosaccharides as host cell receptor determinants. Proc Natl Acad Sci U S A (1980) 1.43
Relationships among the polypeptides of Newcastle disease virus. J Virol (1975) 1.43
Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J Clin Invest (2005) 1.42
Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2. J Virol (1994) 1.41
Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs. Infect Immun (1983) 1.39
Mutants of Sindbis virus. III. Host polypeptides present in purified HR and ts103 virus particles. J Virol (1978) 1.34
Synthesis of Newcastle disease virus polypeptides in a wheat germ cell-free system. J Virol (1977) 1.34
A mutant CHO-K1 strain with resistance to Pseudomonas exotoxin A and alphaviruses fails to cleave Sindbis virus glycoprotein PE2. J Virol (1991) 1.33
Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne. J Virol (1990) 1.33
Dengue virus-induced modifications of host cell membranes. J Virol (1975) 1.33
Loss on serial passage of rhesus monkey kidney cells of proteolytic activity required for Sendai virus activation. Infect Immun (1978) 1.32
Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies. J Virol (1989) 1.30
Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein. Proc Natl Acad Sci U S A (2012) 1.30
Analysis of Sendai virus mRNAs with cDNA clones of viral genes and sequences of biologically important regions of the fusion protein. Proc Natl Acad Sci U S A (1984) 1.30
Conformational change in a viral glycoprotein during maturation due to disulfide bond disruption. Proc Natl Acad Sci U S A (1987) 1.28
Protease cleavage of reovirus capsid protein mu1/mu1C is blocked by alkyl sulfate detergents, yielding a new type of infectious subvirion particle. J Virol (1998) 1.27
Cell surface expression and orientation in membranes of the 44-amino-acid SH protein of simian virus 5. J Virol (1988) 1.27
Role of a single amino acid at the amino terminus of the simian virus 5 F2 subunit in syncytium formation. J Virol (1997) 1.26
Comparison of the relative roles of the F and HN surface glycoproteins of the paramyxovirus simian virus 5 in inducing protective immunity. J Virol (1987) 1.26
Subcellular localization and calcium and pH requirements for proteolytic processing of the Hendra virus fusion protein. J Virol (2004) 1.23
Glycoproteins of Sendai virus are transmembrane proteins. Proc Natl Acad Sci U S A (1979) 1.22
Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2. J Virol (1993) 1.22
Further characterization of the complementation group B temperature-sensitive mutant of respiratory syncytial virus. J Virol (1977) 1.21
Sulfated components of enveloped viruses. J Virol (1975) 1.21
Differences in the role of the cytoplasmic domain of human parainfluenza virus fusion proteins. J Virol (1995) 1.21
Structural changes in the membrane of vero cells infected with a paramyxovirus. J Cell Biol (1975) 1.20
Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation. J Virol (2003) 1.20
Inhibition of respiratory syncytial virus-host cell interactions by mono- and diamidines. Antimicrob Agents Chemother (1981) 1.19
Inhibition of neutrophil lysosome-phagosome fusion associated with influenza virus infection in vitro. Role in depressed bactericidal activity. J Clin Invest (1982) 1.17
Nucleotide sequence of a Sendai virus genome region covering the entire M gene and the 3' proximal 1013 nucleotides of the F gene. Nucleic Acids Res (1984) 1.16
Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology (1975) 6.90
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis (1980) 4.61
Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity. Virology (1969) 4.45
Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology (1977) 4.33
The gene structure and replication of influenza virus. Annu Rev Biochem (1983) 4.30
Evidence for a ninth influenza viral polypeptide. Virology (1978) 4.21
Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology (1972) 4.05
An electron microscopic study of moderate and virulent virus-cell interactions of the parainfluenza virus SV5. Virology (1966) 4.03
Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions. J Virol (1971) 4.02
Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology (1971) 3.96
On the role of the response of the cell membrane in determining virus virulence. Contrasting effects of the parainfluenza virus SV5 in two cell types. J Exp Med (1966) 3.71
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology (1980) 3.53
Isolation and purification of the envelope proteins of Newcastle disease virus. J Virol (1973) 3.49
Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med (1980) 3.32
The synthesis of sendai virus polypeptides in infected cells. Virology (1976) 3.26
Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription. Virology (1976) 3.13
A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc Natl Acad Sci U S A (1983) 3.08
Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells. Proc Natl Acad Sci U S A (1970) 2.73
Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol (1971) 2.68
Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc Natl Acad Sci U S A (1980) 2.60
Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc Natl Acad Sci U S A (1979) 2.58
Nucleocapsid protein subunits of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1970) 2.58
On the role of microtubules in movement and alignment of nuclei in virus-induced syncytia. J Cell Biol (1968) 2.53
Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J (2001) 2.51
The proteins of the parainfluenza virus SV5. 1. Separation of virion polypeptides by polyacrylamide gel electrophoresis. Virology (1969) 2.50
The synthesis of Sendai virus polypeptides in infected cells. III. Phosphorylation of polypeptides. Virology (1977) 2.48
Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells. Virology (1969) 2.48
Isolation and properties of the helical nucleocapsid of the parainfluenza virus SV5. Proc Natl Acad Sci U S A (1967) 2.46
Proteins and glycoproteins of paramyxoviruses: a comparison of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1971) 2.44
The proteins of the parainfluenza virus SV5. II. The carbohydrate content and glycoproteins of the virion. Virology (1970) 2.37
Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1979) 2.33
Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. Virology (1981) 2.26
Polypeptide synthesis in simian virus 5-infected cells. J Virol (1977) 2.20
Reconstitution of membranes with individual paramyxovirus glycoproteins and phospholipid in cholate solution. Virology (1979) 2.20
Determination by peptide mapping of the unique polypeptides in Sendai virions and infected cells. Virology (1978) 2.17
Horizontal transmission of HIV infection between two siblings. Lancet (1986) 2.17
A comparison of the polypeptides of four measles virus strains. Virology (1977) 2.15
Activation of the Sendai virus fusion protein (f) involves a conformational change with exposure of a new hydrophobic region. J Biol Chem (1981) 2.04
Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen. Virology (1973) 2.01
Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action. Virology (1983) 2.00
Cell-fusing activity of visna virus particles. Virology (1967) 1.98
Protease activation mutants of sendai virus. Activation of biological properties by specific proteases. Virology (1976) 1.95
Immunological studies of the functions of paramyxovirus glycoproteins. Virology (1981) 1.93
the relationship of conformational changes in the Sendai virus nucleocapsid to proteolytic cleavage of the NP polypeptide. Virology (1981) 1.85
Phenotypic mixing of envelope proteins of the parainfluenza virus SV5 and vesicular stomatitis virus. J Virol (1970) 1.85
Complete nucleotide sequence of the neuraminidase gene of influenza B virus. Proc Natl Acad Sci U S A (1982) 1.85
Involvement of microtubules and 10-nm filaments in the movement and positioning of nuclei in syncytia. J Cell Biol (1979) 1.78
In vitro synthesis of structural and nonstructural proteins of Sendai and SV5 viruses. Virology (1980) 1.78
Conformation of the helical nucleocapsids of paramyxoviruses and vesicular stomatitis virus: reversible coiling and uncoiling induced by changes in salt concentration. Proc Natl Acad Sci U S A (1980) 1.76
Segment-specific and common nucleotide sequences in the noncoding regions of influenza B virus genome RNAs. Proc Natl Acad Sci U S A (1987) 1.75
The polypeptides of canine distemper virus: synthesis in infected cells and relatedness to the polypeptides of other morbilliviruses. Virology (1980) 1.69
Plaque assay of Visna virus using a secondary cellular overlay as an indicator. Virology (1967) 1.68
Parainfluenza virus surface projections: glycoproteins with haemagglutinin and neuraminidase activities. J Gen Virol (1971) 1.62
Measles virus polypeptides synthesis in infected cells. Virology (1978) 1.61
Infection with paramyxoviruses stimulates synthesis of cellular polypeptides that are also stimulated in cells transformed by Rous sarcoma virus or deprived of glucose. Proc Natl Acad Sci U S A (1978) 1.55
Congenital infections with human herpesvirus 6. J Infect Dis (1998) 1.51
Synthesis of influenza virus polypeptides in cells resistant to alpha-amanitin: evidence for the involvement of cellular RNA polymerase II in virus replication. J Virol (1977) 1.49
Proteolytic cleavage of subunits of the nucleocapsid of the paramyxovirus simian virus 5. J Virol (1974) 1.49
Evidence for lack of synthesis of the M polypeptide of measles virus in brain cells in subacute sclerosing panencephalitis. Virology (1979) 1.48
Measles-virus proteins in the brain tissue of patients with subacute sclerosing panencephalitis: absence of the M protein. N Engl J Med (1981) 1.48
Plasma membrane lipids and parainfluenza virus assembly. Virology (1970) 1.44
Proteolytic cleavage of the hemagglutinin polypeptide of influenza virus. Function of the uncleaved polypeptide HA. Virology (1973) 1.43
Replication of SV5 RNA and the effects of superinfection with poliovirus. Virology (1967) 1.43
The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA. RNA (2001) 1.42
Chemical composition of the parainfluenza virus SV5. Virology (1969) 1.39
The RNAs of infective and incomplete influenza virions grown in MDBK and HeLa cells. Virology (1970) 1.37
The hemagglutinating and neuraminidase protein of a paramyxovirus: interaction with neuraminic acid in affinity chromatography. Virology (1974) 1.36
The length of the helical nucleocapsid of Newcastle disease virus. Virology (1967) 1.36
Loss on serial passage of rhesus monkey kidney cells of proteolytic activity required for Sendai virus activation. Infect Immun (1978) 1.32
Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J Virol (1996) 1.32
A comparison of immune cytolysis and virus-induced fusion of sensitive and resistant cell types. Proc Soc Exp Biol Med (1969) 1.31
The nucleic acid of the parainfluenza virus SV5. Virology (1968) 1.30
Analysis of Sendai virus mRNAs with cDNA clones of viral genes and sequences of biologically important regions of the fusion protein. Proc Natl Acad Sci U S A (1984) 1.30
Studies on the helical nucleocapsid of influenza virus. Virology (1982) 1.27
Studies on pneumonia virus of mice (PVM) in cell culture. I. Replication in baby hamster kidney cells and properties of the virus. J Exp Med (1967) 1.25
Studies on pneumonia virus of mice (PVM) in cell culture. II. Structure and morphogenesis of the virus particle. J Exp Med (1967) 1.24
The carbohydrate structure of the glycoproteins of the paramyxovirus SV5 grown in bovine kidney cells. J Biol Chem (1979) 1.22
Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J Virol (1995) 1.20
The synthesis of Sendai virus polypeptides in infected cells. II. Intracellular distribution of polypeptides. Virology (1977) 1.14
Fusion of Sendai virus with liposomes: dependence on the viral fusion protein (F) and the lipid composition of liposomes. Virology (1983) 1.14
The transcriptase complex of the paramyxovirus SV5. Virology (1977) 1.12